I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel DiseaseLaurent Peyrin‐Biroulet, Gilles Macaigne, Guillaume Pineton de Chambrun et al.|Clinical Gastroenterology and Hepatology|2022Cited by 38
Adalimumab in Biologic-naïve Patients With Crohn’s Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAIDYoram Bouhnik, Claire Painchart, Guillaume Pineton de Chambrun et al.|Clinical Gastroenterology and Hepatology|2023Cited by 23
The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort StudyAurélien Amiot, Fabiana Castiglione, Jean‐François Rahier et al.|Journal of Crohn s and Colitis|2022Cited by 14
457 ADALIMUMAB FOR PATIENTS WITH CROHN'S DISEASE COMPLICATED BY INTRA-ABDOMINAL ABSCESS : LONG-TERM RESULTS OF THE MICA STUDYGuillaume Pineton de Chambrun, Yoram Bouhnik, Benjamin Pariente et al.|Gastroenterology|2021Cited by 2
Building a Robust Investigator-Initiated Platform: The I-CARE ExperienceKirchgesner J, Stephane Nancey, Beaugerie L et al.|Cineca Institutional Research Information System (Tor Vergata University)|2026Cited by 0